Dual effect of serum amyloid a on the invasiveness of glioma cells

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Knebel, Franciele Hinterholz ^a   Albuquerque, Renata Chaves ^a   Massaro, Renato Ramos ^a   Maria Engler, Silvya Stuchi ^a   Campa, Ana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; SERUM AMYLOID A; SERUM AMYLOID A1; SERUM AMYLOID A2; SERUM AMYLOID A4; SUPEROXIDE; THYMIDINE; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; CELL MOTION; DRUG EFFECT; GLIOMA; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLIOMA; HUMANS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM AMYLOID A PROTEIN;

EID: 84875669135     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/509089     Document Type: Article

References (57)

1. Patel H., Fellowes R., Coade S., Woo P., Human serum amyloid A has cytokine-like properties. Scandinavian Journal of Immunology 1998 48 4 410 418 2-s2.0-0031754163 10.1046/j.1365-3083.1998.00394.x (Pubitemid 28459659)
2. Uhlar C. M., Whitehead A. S., Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 1999 265 2 501 523 2-s2.0-0033569982 10.1046/j.1432-1327.1999.00657.x (Pubitemid 29488982)
3. Urieli-Shoval S., Linke R. P., Matzner Y., Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Current Opinion in Hematology 2000 7 1 64 69 2-s2.0-0033988643 10.1097/00062752-200001000-00012 (Pubitemid 30007690)
4. Malle E., Sodin-Semrl S., Kovacevic A., Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cellular and Molecular Life Sciences 2009 66 1 9 26 2-s2.0-58149515783 10.1007/s00018-008-8321-x
5. Khan N., Cromer C. J., Campa M., Patz E. F., Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 2004 101 2 379 384 2-s2.0-3042781120 10.1002/cncr.20377 (Pubitemid 38890843)
6. Cho W. C. S., Yip T. T. C., Yip C., Yip V., Thulasiraman V., Ngan R. K. C., Yip T. T., Lau W. H., Au J. S. K., Law S. C. K., Cheng W. W., Ma V. W. S., Lim C. K. P., Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clinical Cancer Research 2004 10 1 I 43 52 2-s2.0-1642453766 10.1158/1078-0432.CCR-0413-3 (Pubitemid 38114160)
7. Moshkovskii S. A., Serebryakova M. V., Kuteykin-Teplyakov K. B., Tikhonova O. V., Goufman E. I., Zgoda V. G., Taranets I. N., Makarov O. V., Archakov A. I., Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics 2005 5 14 3790 3797 2-s2.0-25844448645 10.1002/pmic.200401205 (Pubitemid 41393309)
8. Pierce B. L., Ballard-Barbash R., Bernstein L., Baumgartner R. N., Neuhouser M. L., Wener M. H., Baumgartner K. B., Gilliland F. D., Sorensen B. E., McTiernan A., Ulrich C. M., Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology 2009 27 21 3437 3444 2-s2.0-70249127607 10.1200/JCO.2008.18. 9068
9. Vlasova M. A., Moshkovskii S. A., Molecular interactions of acute phase serum amyloid A: possible involvement in carcinogenesis. Biochemistry 2006 71 10 1051 1059 2-s2.0-33750333142 10.1134/S0006297906100014 (Pubitemid 44630335)
10. Upragarin N., Landman W. J. M., Gaastra W., Gruys E., Extrahepatic production of acute phase serum amyloid A. Histology and Histopathology 2005 20 4 1295 1307 2-s2.0-27144498164 (Pubitemid 41489172)
11. Hatanaka E., Dermargos A., Armelin H. A., Curi R., Campa A., Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast. Clinical and Experimental Immunology 2011 163 3 362 367 2-s2.0-79551700105 10.1111/j.1365-2249.2010.04300.x
12. Filippin-Monteiro F. B., de Oliveira E. M., Sandri S., Knebel F. H., Albuquerque R. C., Campa A., Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance. International Journal of Obesity 2011 1 1 1 8 10.1038/ijo.2011.193
13. Sandri S., Rodriguez D., Gomes E., Monteiro H. P., Russo M., Campa A., Is serum amyloid A an endogenous TLR4 agonist? Journal of Leukocyte Biology 2008 83 5 1174 1180 2-s2.0-46949110787 10.1189/jlb.0407203 (Pubitemid 351960349)
14. Hatanaka E., Ribeiro F. P., Campa A., The acute phase protein serum amyloid A primes neutrophils. FEMS Immunology and Medical Microbiology 2003 38 1 81 84 2-s2.0-0142061149 10.1016/S0928-8244(03)00112-3 (Pubitemid 37297447)
15. Michaeli A., Finci-Yeheskel Z., Dishon S., Linke R. P., Levin M., Urieli-Shoval S., Serum amyloid A enhances plasminogen activation: implication for a role in colon cancer. Biochemical and Biophysical Research Communications 2008 368 2 368 373 2-s2.0-39649118624 10.1016/j.bbrc.2008.01.079
16. Paret C., Schön Z., Szponar A., Kovacs G., Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. European Urology 2010 57 5 859 866 2-s2.0-77949488296 10.1016/j.eururo.2009.08.014
17. Migita K., Kawabe Y., Tominaga M., Origuchi T., Aoyagi T., Eguchi K., Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Laboratory Investigation 1998 78 5 535 539 2-s2.0-0031805385 (Pubitemid 28246977)
18. Preciado-Patt L., Hershkoviz R., Fridkin M., Lider O., Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. Journal of Immunology 1996 156 3 1189 1195 2-s2.0-0030043750 (Pubitemid 26048116)
19. Su S. B., Gong W., Gao J. L., Shen W., Murphy P. M., Oppenheim J. J., Wang J. M., A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. Journal of Experimental Medicine 1999 189 2 395 402 2-s2.0-0000485181 10.1084/jem.189.2.395 (Pubitemid 29063260)
20. Badolato R., Wang J. M., Murphy W. J., Lloyd A. R., Michiel D. F., Bausserman L. L., Kelvin D. J., Oppenheim J. J., Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. Journal of Experimental Medicine 1994 180 1 203 209 2-s2.0-23444460848 10.1084/jem.180.1.203 (Pubitemid 24181069)
21. Connolly M., Marrelli A., Blades M., McCormick J., Maderna P., Godson C., Mullan R., FitzGerald O., Bresnihan B., Pitzalis C., Veale D. J., Fearon U., Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. Journal of Immunology 2010 184 11 6427 6437 2-s2.0-77953431572 10.4049/jimmunol.0902941
22. Ware M. L., Berger M. S., Binder D. K., Molecular biology of glioma tumorigenesis. Histology and Histopathology 2003 18 1 207 216 2-s2.0-0037215932 (Pubitemid 36040462)
23. Amirian E., Liu Y., Scheurer M. E., El-Zein R., Gilbert M. R., Bondy M. L., Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro-Oncology 2010 12 5 444 452 2-s2.0-77954711621 10.1093/neuonc/nop057
24. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
25. Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N. S., Jourd'Heuil D., Kelm M., Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB Journal 2002 16 13 1775 1785 2-s2.0-0036846736 10.1096/fj.02-0363com (Pubitemid 35340358)
26. Egeblad M., Werb Z., New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2002 2 3 161 174 2-s2.0-0036512208 (Pubitemid 37328786)
27. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 2008 454 7203 436 444 2-s2.0-47949096781 10.1038/nature07205
28. Szatrowski T. P., Nathan C. F., Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research 1991 51 3 794 798 2-s2.0-0026021362
29. Lala P. K., Chakraborty C., Role of nitric oxide in carcinogenesis and tumour progression. The Lancet Oncology 2001 2 3 149 156 2-s2.0-0035296203 10.1016/S1470-2045(00)00256-4 (Pubitemid 33585926)
30. Sandri S., Hatanaka E., Franco A. G., Pedrosa A. M. C., Monteiro H. P., Campa A., Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signaling pathways. Immunology Letters 2008 121 1 22 26 2-s2.0-54049115029 10.1016/j.imlet.2008.07.013
31. Ribeiro F. P., Furlaneto C. J., Hatanaka E., Ribeiro W. B., Souza G. M., Cassatella M. A., Campa A., mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators of Inflammation 2003 12 3 173 178 2-s2.0-0037765331 10.1080/0962935031000134897 (Pubitemid 36871853)
32. Hatanaka E., Furlaneto C. J., Ribeiro F. P., Souza G. M., Campa A., Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF- α) in human neutrophils. Immunology Letters 2004 91 1 33 37 2-s2.0-0742324472 10.1016/j.imlet.2003.09.011 (Pubitemid 38147743)
33. Preciado-Patt L., Cahalon L., Hershkovitz R., Lider O., Pras M., Fridkin M., Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor- α by human T-lymphocytes. Letters in Peptide Science 1998 5 5-6 349 355 2-s2.0-0000167117 (Pubitemid 128511617)
34. Nabeshima K., Inoue T., Shimao Y., Sameshima T., Matrix metalloproteinases in tumor invasion: role for cell migration. Pathology International 2002 52 4 255 264 2-s2.0-0035990901 10.1046/j.1440-1827.2002. 01343.x (Pubitemid 34587810)
35. Rao J. S., Molecular mechanisms of glioma invasiveness: the role of proteases. Nature Reviews Cancer 2003 3 7 489 501 2-s2.0-0041737535 (Pubitemid 37328837)
36. Lee H. Y., Kim M. K., Park K. S., Bae Y. H., Yun J., Park J. I., Kwak J. Y., Bae Y. S., Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochemical and Biophysical Research Communications 2005 330 3 989 998 2-s2.0-16244412633 10.1016/j.bbrc.2005.03.069 (Pubitemid 40462183)
37. Mullan R. H., Bresnihan B., Golden-Mason L., Markham T., O'Hara R., FitzGerald O., Veale D. J., Fearon U., Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF- B-dependent signal transduction pathway. Arthritis and Rheumatism 2006 54 1 105 114 2-s2.0-31044456300 10.1002/art.21518 (Pubitemid 43122193)
38. Ohgaki H., Kleihues P., Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Science 2009 100 12 2235 2241 2-s2.0-70449711757 10.1111/j.1349-7006.2009.01308.x
39. Ishii N., Maier D., Merlo A., Tada M., Sawamura Y., Diserens A. C., Van Meir E. G., Frequent Co-alterations of TP53, p16/CDKN2A, p14(ARF), PTEN tumor suppressor genes in human glioma cell lines. Brain Pathology 1999 9 3 469 479 2-s2.0-0032977124 (Pubitemid 29316287)
40. Zhang R., Banik N. L., Ray S. K., Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. Brain Research 2008 1239 C 216 225 2-s2.0-53949100236 10.1016/j.brainres.2008.08.075
41. Yao Y., Kubota T., Sato K., Takeuchi H., Handa Y., Matsukawa S., Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells. Journal of Neuro-Oncology 2006 76 3 219 225 2-s2.0-33645315210 10.1007/s11060-005-6498-5
42. Costa F. F., Colin C., Shinjo S. M. O., Zanata S. M., Marie S. K. N., Sogayar M. C., Camargo A. A., ADAM23 methylation and expression analysis in brain tumors. Neuroscience Letters 2005 380 3 260 264 2-s2.0-18144427531 10.1016/j.neulet.2005.01.050 (Pubitemid 40616092)
43. Schlenska-Lange A., Knüpfer H., Lange T. J., Kiess W., Knüpfer M., Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro. Anticancer Research 2008 28 2 A 1055 1060 2-s2.0-42549145434 (Pubitemid 351578954)
44. Konno H., Ohta M., Baba M., Suzuki S., Nakamura S., The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Science 2003 94 8 735 740 2-s2.0-0141702099 10.1111/j.1349-7006.2003.tb01511.x (Pubitemid 37160933)
45. Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K., Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Science 2007 98 7 1048 1054 2-s2.0-34249907598 10.1111/j.1349-7006.2007.00507.x (Pubitemid 46865390)
46. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., Kuwano M., Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Molecular and Cellular Biology 1997 17 7 4015 4023 2-s2.0-0031009807 (Pubitemid 27281877)
47. Furlaneto C. J., Campa A., A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor- α interleukin-1 β and interleukin-8 by human blood neutrophil. Biochemical and Biophysical Research Communications 2000 268 2 405 408 2-s2.0-0034673318 10.1006/bbrc.2000.2143 (Pubitemid 30119635)
48. Jijon H. B., Madsen K. L., Walker J. W., Allard B., Jobin C., Serum amyloid A activates NF- B and proinflammatory gene expression in human and murine intestinal epithelial cells. European Journal of Immunology 2005 35 3 718 726 2-s2.0-15844411922 10.1002/eji.200425688 (Pubitemid 40425527)
49. Fetz V., Bier C., Habtemichael N., Schuon R., Schweitzer A., Kunkel M., Engels K., Kovács A. F., Schneider S., Mann W., Stauber R. H., Knauer S. K., Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. International Journal of Cancer 2009 124 9 2033 2041 2-s2.0-63449100912 10.1002/ijc.24182
50. Rieger J., Ständer M., Löschmann P. A., Heneka M., Dichgans J., Klockgether T., Weller M., Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF- β dexamethasone, and p53 gene transfer. Oncogene 1998 17 18 2323 2332 2-s2.0-0032487830 (Pubitemid 28515385)
51. Bedard K., Krause K. H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005 (Pubitemid 46209993)
52. Yoshimura A., Signal transduction of inflammatory cytokines and tumor development. Cancer Science 2006 97 6 439 447 2-s2.0-33744548730 10.1111/j.1349-7006.2006.00197.x (Pubitemid 43811583)
53. Maeda S., Omata M., Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Science 2008 99 5 836 842 2-s2.0-43649109029 10.1111/j.1349-7006.2008.00763.x (Pubitemid 352002583)
54. Reynés G., Vila V., Martin M., Parada A., Fleitas T., Reganon E., Marti'nez-Sales V., Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. Journal of Neuro-Oncology 2010 102 1 35 41 10.1007/s11060-010-0290-x
55. Anderson J. C., Mcfarland B. C., Gladson C. L., New molecular targets in angiogenic vessels of glioblastoma tumours. Expert Reviews in Molecular Medicine 2008 10 23, article e23 2-s2.0-49549122025 10.1017/S1462399408000768
56. Hoelzinger D. B., Demuth T., Berens M. E., Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. Journal of the National Cancer Institute 2007 99 21 1583 1593 2-s2.0-36048994736 10.1093/jnci/djm187 (Pubitemid 351767231)
57. Jung S., Kim H. W., Lee J. H., Kang S. S., Rhu H. H., Jeong Y. I., Yang S. Y., Chung H. Y., Bae C. S., Choi C., Shin B. A., Kim K. K., Ahn K. Y., Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. Journal of Cancer Research and Clinical Oncology 2002 128 9 469 476 2-s2.0-0036381552 10.1007/s00432-002-0366-x